AHB
EW icon

Abner Herrman & Brock’s Edwards Lifesciences EW Stock Holding History

Abner Herrman & Brock’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Sell
6,579
-800
-11% -$67K 0.06% 66
2026
Q1 		$591K Buy
7,379
+84
+1% +$6.92K 0.07% 64
2025
Q4 		$622K Sell
7,295
-300
-4% -$24.6K 0.06% 67
2025
Q3 		$591K Buy
+7,595
New +$593K 0.06% 70
2024
Q4 		– Sell
-10,225
Closed -$675K – 67
2024
Q3 		$675K Sell
10,225
-1,206
-11% -$87.6K 0.08% 61
2024
Q2 		$1.06M Sell
11,431
-760
-6% -$67.3K 0.13% 55
2024
Q1 		$1.17M Sell
12,191
-2
-0% -$168 0.15% 53
2023
Q4 		$930K Sell
12,193
-19,737
-62% -$1.37M 0.13% 56
2023
Q3 		$2.21M Sell
31,930
-7,019
-18% -$564K 0.34% 50
2023
Q2 		$3.67M Sell
38,949
-1,237
-3% -$108K 0.54% 42
2023
Q1 		$3.33M Sell
40,186
-1,835
-4% -$144K 0.5% 43
2022
Q4 		$3.13M Sell
42,021
-12,061
-22% -$930K 0.48% 44
2022
Q3 		$4.47M Buy
54,082
+790
+1% +$76K 0.82% 37
2022
Q2 		$5.07M Buy
53,292
+150
+0.3% +$15.5K 0.87% 36
2022
Q1 		$6.26M Buy
53,142
+2,405
+5% +$270K 0.88% 34
2021
Q4 		$6.57M Buy
50,737
+3,003
+6% +$350K 0.86% 37
2021
Q3 		$5.4M Buy
47,734
+1,393
+3% +$159K 0.76% 38
2021
Q2 		$4.8M Buy
46,341
+3,280
+8% +$309K 0.67% 41
2021
Q1 		$3.6M Sell
43,061
-24,610
-36% -$2.08M 0.54% 42
2020
Q4 		$6.17M Sell
67,671
-13,284
-16% -$1.1M 0.96% 35
2020
Q3 		$6.46M Buy
80,955
+25,465
+46% +$1.99M 1.09% 32
2020
Q2 		$3.83M Sell
55,490
-385
-0.7% -$27.4K 0.69% 40
2020
Q1 		$3.51M Sell
55,875
-1,659
-3% -$120K 0.8% 36
2019
Q4 		$4.47M Sell
57,534
-750
-1% -$58.6K 0.67% 39
2019
Q3 		$4.27M Buy
+58,284
New +$4.09M 0.63% 37

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Abner Herrman & Brock's EW Position: Q2 2026 in Review

Abner Herrman & Brock reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $67K and leaving 6,579 shares worth $595K. The position accounts for 0.06% of the portfolio, ranked #66.

Abner Herrman & Brock first reported a position in EW in Q3 2019 and has held it in 25 quarters since. The position peaked at $6.57M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Abner Herrman & Brock held 6,579 shares of Edwards Lifesciences worth $595K as of Q2 2026.
  • Abner Herrman & Brock sold 800 Edwards Lifesciences shares in Q2 2026, an estimated $67K.
  • Edwards Lifesciences made up 0.06% of Abner Herrman & Brock's portfolio in Q2 2026, its #66 holding.
  • Abner Herrman & Brock first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 25 quarters since.
  • Abner Herrman & Brock's Edwards Lifesciences position peaked at $6.57M in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.